# Jazz Pharmaceuticals to Highlight Neuro-Oncology Clinical Research at SNO 2026

- Source: PR Newswire M&A
- Published: 2026-11-02T13:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-highlight-neuro-oncology-clinical-research-at-sno-2026-302926439.html
- Canonical: https://groundlevelnews.com/story/jazz-pharmaceuticals-to-highlight-neuro-oncology-clinical-research-at--ae2cac/

Presentations showcase Phase 3 ACTION trial progress and continued development of novel therapies for rare brain cancers For U.S. media and investors only DUBLIN, Nov. 2, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that clinical and preclinical research...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._